Review



fda approved kinase inhibitor compounds  (TargetMol)


Bioz Verified Symbol TargetMol is a verified supplier
Bioz Manufacturer Symbol TargetMol manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    TargetMol fda approved kinase inhibitor compounds
    Fda Approved Kinase Inhibitor Compounds, supplied by TargetMol, used in various techniques. Bioz Stars score: 99/100, based on 27 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fda approved kinase inhibitor compounds/product/TargetMol
    Average 99 stars, based on 27 article reviews
    fda approved kinase inhibitor compounds - by Bioz Stars, 2026-03
    99/100 stars

    Images



    Similar Products

    94
    LGC Standards certified reference materials
    Certified Reference Materials, supplied by LGC Standards, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/certified reference materials/product/LGC Standards
    Average 94 stars, based on 1 article reviews
    certified reference materials - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    96
    MedChemExpress compound c
    Effects of inhibiting and activating AMPK signaling on the AdipoRon-mediated mitigation of lipotoxicity-induced injury in LMH cells. (A) Oil Red O staining results for LMH cells. (B) TG and TC contents in LMH cells. (C) GPT and GOT activity levels in LMH cells. Abbreviations: C, control group; H, mixed fatty acid (0.30 mM OA + 0.15 mM PA)-treated group; H+MA, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon-treated group; H+MA+C, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 10 μM Compound C-treated group; H+MA+A, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 0.5 mM AICAR-treated group; OA, oleic acid; PA, palmitic acid; TG, triglyceride; TC, total cholesterol; GPT, glutamic pyruvic transaminase; GOT, glutamic oxaloacetic transaminase. All the data are expressed as the mean±SEM. * indicates P <0.05; ** indicates P <0.01; *** indicates P <0.001; ⁎⁎⁎⁎ indicates P <0.0001.
    Compound C, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/compound c/product/MedChemExpress
    Average 96 stars, based on 1 article reviews
    compound c - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    99
    TargetMol fda approved kinase inhibitor compounds
    Effects of inhibiting and activating AMPK signaling on the AdipoRon-mediated mitigation of lipotoxicity-induced injury in LMH cells. (A) Oil Red O staining results for LMH cells. (B) TG and TC contents in LMH cells. (C) GPT and GOT activity levels in LMH cells. Abbreviations: C, control group; H, mixed fatty acid (0.30 mM OA + 0.15 mM PA)-treated group; H+MA, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon-treated group; H+MA+C, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 10 μM Compound C-treated group; H+MA+A, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 0.5 mM AICAR-treated group; OA, oleic acid; PA, palmitic acid; TG, triglyceride; TC, total cholesterol; GPT, glutamic pyruvic transaminase; GOT, glutamic oxaloacetic transaminase. All the data are expressed as the mean±SEM. * indicates P <0.05; ** indicates P <0.01; *** indicates P <0.001; ⁎⁎⁎⁎ indicates P <0.0001.
    Fda Approved Kinase Inhibitor Compounds, supplied by TargetMol, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fda approved kinase inhibitor compounds/product/TargetMol
    Average 99 stars, based on 1 article reviews
    fda approved kinase inhibitor compounds - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    TargetMol library of 278 fda approved kinase inhibitor compounds
    Effects of inhibiting and activating AMPK signaling on the AdipoRon-mediated mitigation of lipotoxicity-induced injury in LMH cells. (A) Oil Red O staining results for LMH cells. (B) TG and TC contents in LMH cells. (C) GPT and GOT activity levels in LMH cells. Abbreviations: C, control group; H, mixed fatty acid (0.30 mM OA + 0.15 mM PA)-treated group; H+MA, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon-treated group; H+MA+C, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 10 μM Compound C-treated group; H+MA+A, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 0.5 mM AICAR-treated group; OA, oleic acid; PA, palmitic acid; TG, triglyceride; TC, total cholesterol; GPT, glutamic pyruvic transaminase; GOT, glutamic oxaloacetic transaminase. All the data are expressed as the mean±SEM. * indicates P <0.05; ** indicates P <0.01; *** indicates P <0.001; ⁎⁎⁎⁎ indicates P <0.0001.
    Library Of 278 Fda Approved Kinase Inhibitor Compounds, supplied by TargetMol, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/library of 278 fda approved kinase inhibitor compounds/product/TargetMol
    Average 99 stars, based on 1 article reviews
    library of 278 fda approved kinase inhibitor compounds - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    TargetMol fda approved compounds
    Effects of inhibiting and activating AMPK signaling on the AdipoRon-mediated mitigation of lipotoxicity-induced injury in LMH cells. (A) Oil Red O staining results for LMH cells. (B) TG and TC contents in LMH cells. (C) GPT and GOT activity levels in LMH cells. Abbreviations: C, control group; H, mixed fatty acid (0.30 mM OA + 0.15 mM PA)-treated group; H+MA, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon-treated group; H+MA+C, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 10 μM Compound C-treated group; H+MA+A, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 0.5 mM AICAR-treated group; OA, oleic acid; PA, palmitic acid; TG, triglyceride; TC, total cholesterol; GPT, glutamic pyruvic transaminase; GOT, glutamic oxaloacetic transaminase. All the data are expressed as the mean±SEM. * indicates P <0.05; ** indicates P <0.01; *** indicates P <0.001; ⁎⁎⁎⁎ indicates P <0.0001.
    Fda Approved Compounds, supplied by TargetMol, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fda approved compounds/product/TargetMol
    Average 99 stars, based on 1 article reviews
    fda approved compounds - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    TargetMol small molecular compounds mg132
    Effects of inhibiting and activating AMPK signaling on the AdipoRon-mediated mitigation of lipotoxicity-induced injury in LMH cells. (A) Oil Red O staining results for LMH cells. (B) TG and TC contents in LMH cells. (C) GPT and GOT activity levels in LMH cells. Abbreviations: C, control group; H, mixed fatty acid (0.30 mM OA + 0.15 mM PA)-treated group; H+MA, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon-treated group; H+MA+C, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 10 μM Compound C-treated group; H+MA+A, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 0.5 mM AICAR-treated group; OA, oleic acid; PA, palmitic acid; TG, triglyceride; TC, total cholesterol; GPT, glutamic pyruvic transaminase; GOT, glutamic oxaloacetic transaminase. All the data are expressed as the mean±SEM. * indicates P <0.05; ** indicates P <0.01; *** indicates P <0.001; ⁎⁎⁎⁎ indicates P <0.0001.
    Small Molecular Compounds Mg132, supplied by TargetMol, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/small molecular compounds mg132/product/TargetMol
    Average 99 stars, based on 1 article reviews
    small molecular compounds mg132 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    93
    TargetMol compounds
    Effects of inhibiting and activating AMPK signaling on the AdipoRon-mediated mitigation of lipotoxicity-induced injury in LMH cells. (A) Oil Red O staining results for LMH cells. (B) TG and TC contents in LMH cells. (C) GPT and GOT activity levels in LMH cells. Abbreviations: C, control group; H, mixed fatty acid (0.30 mM OA + 0.15 mM PA)-treated group; H+MA, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon-treated group; H+MA+C, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 10 μM Compound C-treated group; H+MA+A, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 0.5 mM AICAR-treated group; OA, oleic acid; PA, palmitic acid; TG, triglyceride; TC, total cholesterol; GPT, glutamic pyruvic transaminase; GOT, glutamic oxaloacetic transaminase. All the data are expressed as the mean±SEM. * indicates P <0.05; ** indicates P <0.01; *** indicates P <0.001; ⁎⁎⁎⁎ indicates P <0.0001.
    Compounds, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/compounds/product/TargetMol
    Average 93 stars, based on 1 article reviews
    compounds - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    99
    TargetMol small molecular compounds 456 mg132
    Effects of inhibiting and activating AMPK signaling on the AdipoRon-mediated mitigation of lipotoxicity-induced injury in LMH cells. (A) Oil Red O staining results for LMH cells. (B) TG and TC contents in LMH cells. (C) GPT and GOT activity levels in LMH cells. Abbreviations: C, control group; H, mixed fatty acid (0.30 mM OA + 0.15 mM PA)-treated group; H+MA, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon-treated group; H+MA+C, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 10 μM Compound C-treated group; H+MA+A, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 0.5 mM AICAR-treated group; OA, oleic acid; PA, palmitic acid; TG, triglyceride; TC, total cholesterol; GPT, glutamic pyruvic transaminase; GOT, glutamic oxaloacetic transaminase. All the data are expressed as the mean±SEM. * indicates P <0.05; ** indicates P <0.01; *** indicates P <0.001; ⁎⁎⁎⁎ indicates P <0.0001.
    Small Molecular Compounds 456 Mg132, supplied by TargetMol, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/small molecular compounds 456 mg132/product/TargetMol
    Average 99 stars, based on 1 article reviews
    small molecular compounds 456 mg132 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    Image Search Results


    Effects of inhibiting and activating AMPK signaling on the AdipoRon-mediated mitigation of lipotoxicity-induced injury in LMH cells. (A) Oil Red O staining results for LMH cells. (B) TG and TC contents in LMH cells. (C) GPT and GOT activity levels in LMH cells. Abbreviations: C, control group; H, mixed fatty acid (0.30 mM OA + 0.15 mM PA)-treated group; H+MA, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon-treated group; H+MA+C, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 10 μM Compound C-treated group; H+MA+A, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 0.5 mM AICAR-treated group; OA, oleic acid; PA, palmitic acid; TG, triglyceride; TC, total cholesterol; GPT, glutamic pyruvic transaminase; GOT, glutamic oxaloacetic transaminase. All the data are expressed as the mean±SEM. * indicates P <0.05; ** indicates P <0.01; *** indicates P <0.001; ⁎⁎⁎⁎ indicates P <0.0001.

    Journal: Poultry Science

    Article Title: The adiponectin receptor agonist AdipoRon alleviates lipotoxic injury in LMH cells

    doi: 10.1016/j.psj.2026.106573

    Figure Lengend Snippet: Effects of inhibiting and activating AMPK signaling on the AdipoRon-mediated mitigation of lipotoxicity-induced injury in LMH cells. (A) Oil Red O staining results for LMH cells. (B) TG and TC contents in LMH cells. (C) GPT and GOT activity levels in LMH cells. Abbreviations: C, control group; H, mixed fatty acid (0.30 mM OA + 0.15 mM PA)-treated group; H+MA, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon-treated group; H+MA+C, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 10 μM Compound C-treated group; H+MA+A, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 0.5 mM AICAR-treated group; OA, oleic acid; PA, palmitic acid; TG, triglyceride; TC, total cholesterol; GPT, glutamic pyruvic transaminase; GOT, glutamic oxaloacetic transaminase. All the data are expressed as the mean±SEM. * indicates P <0.05; ** indicates P <0.01; *** indicates P <0.001; ⁎⁎⁎⁎ indicates P <0.0001.

    Article Snippet: To determine whether AdipoRon alleviates mixed fatty acid-induced lipotoxic injury in LMH cells via AMPK signaling, the cells were grouped and treated as follows: cells in the control group (Group C) were cultured in normal serum-free medium; cells in the model group (Group H) were cultured in serum-free medium supplemented with mixed fatty acids (0.30 mM OA + 0.15 mM PA); cells in the fatty acid + medium AdipoRon group (Group H+MA) were cultured in serum-free medium supplemented with mixed fatty acids (0.30 mM OA + 0.15 mM PA) and 40 μM AdipoRon; cells in the AMPK antagonist Compound C group (Group H+MA+C) were cultured in serum-free medium supplemented with mixed fatty acids (0.30 mM OA + 0.15 mM PA), 40 μM AdipoRon, and 10 μM Compound C (Cat# HY-13418A, MedChemExpress); and cells in the AMPK agonist Acadesine (AICAR) group (Group H+MA+A) were cultured in serum-free medium supplemented with mixed fatty acids (0.30 mM OA + 0.15 mM PA), 40 μM AdipoRon, and 0.5 mM AICAR (Cat# HY-13417, MedChemExpress).

    Techniques: Staining, Activity Assay, Control

    Effects of inhibiting and activating AMPK signaling on the mRNA expression of lipid metabolism-related genes in LMH cells. (A) Lipid synthesis-related genes. (B) Fatty acid β-oxidation-related genes. Abbreviations: C, control group; H, mixed fatty acid (0.30 mM OA + 0.15 mM PA)-treated group; H+MA, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon-treated group; H+MA+C, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 10 μM Compound C-treated group; H+MA+A, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 0.5 mM AICAR-treated group; OA, oleic acid; PA, palmitic acid; ACC, acetyl-CoA carboxylase; SCD-1, stearyl coenzyme A dehydrogenase-1; ACOX-1, acyl-CoA oxidase 1; CPT-1, carnitine palmitoyltransferase 1. All the data are expressed as the mean±SEM. * indicates P <0.05; ** indicates P <0.01; *** indicates P <0.001; ⁎⁎⁎⁎ indicates P <0.0001.

    Journal: Poultry Science

    Article Title: The adiponectin receptor agonist AdipoRon alleviates lipotoxic injury in LMH cells

    doi: 10.1016/j.psj.2026.106573

    Figure Lengend Snippet: Effects of inhibiting and activating AMPK signaling on the mRNA expression of lipid metabolism-related genes in LMH cells. (A) Lipid synthesis-related genes. (B) Fatty acid β-oxidation-related genes. Abbreviations: C, control group; H, mixed fatty acid (0.30 mM OA + 0.15 mM PA)-treated group; H+MA, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon-treated group; H+MA+C, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 10 μM Compound C-treated group; H+MA+A, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 0.5 mM AICAR-treated group; OA, oleic acid; PA, palmitic acid; ACC, acetyl-CoA carboxylase; SCD-1, stearyl coenzyme A dehydrogenase-1; ACOX-1, acyl-CoA oxidase 1; CPT-1, carnitine palmitoyltransferase 1. All the data are expressed as the mean±SEM. * indicates P <0.05; ** indicates P <0.01; *** indicates P <0.001; ⁎⁎⁎⁎ indicates P <0.0001.

    Article Snippet: To determine whether AdipoRon alleviates mixed fatty acid-induced lipotoxic injury in LMH cells via AMPK signaling, the cells were grouped and treated as follows: cells in the control group (Group C) were cultured in normal serum-free medium; cells in the model group (Group H) were cultured in serum-free medium supplemented with mixed fatty acids (0.30 mM OA + 0.15 mM PA); cells in the fatty acid + medium AdipoRon group (Group H+MA) were cultured in serum-free medium supplemented with mixed fatty acids (0.30 mM OA + 0.15 mM PA) and 40 μM AdipoRon; cells in the AMPK antagonist Compound C group (Group H+MA+C) were cultured in serum-free medium supplemented with mixed fatty acids (0.30 mM OA + 0.15 mM PA), 40 μM AdipoRon, and 10 μM Compound C (Cat# HY-13418A, MedChemExpress); and cells in the AMPK agonist Acadesine (AICAR) group (Group H+MA+A) were cultured in serum-free medium supplemented with mixed fatty acids (0.30 mM OA + 0.15 mM PA), 40 μM AdipoRon, and 0.5 mM AICAR (Cat# HY-13417, MedChemExpress).

    Techniques: Expressing, Control

    Effects of inhibiting and activating AMPK signaling on the expression of key signaling molecules of adiponectin that regulate lipid metabolism in LMH cells. (A) Relative mRNA expression of AdipoR1, AdipoR2, and AMPK. (B) Protein expression of AdipoR1, AdipoR2, AMPK, and p-AMPK. Abbreviations: C, control group; H, mixed fatty acid (0.30 mM OA + 0.15 mM PA)-treated group; H+MA, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon-treated group; H+MA+C, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 10 μM Compound C-treated group; H+MA+A, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 0.5 mM AICAR-treated group; OA, oleic acid; PA, palmitic acid; AdipoR1, adiponectin receptor 1; AdipoR2, adiponectin receptor 2; AMPK, adenosine 5′-monophosphate-activated protein kinase. All data are expressed as the mean±SEM. * indicates P <0.05; ** indicates P <0.01; *** indicates P <0.001; ⁎⁎⁎⁎ indicates P <0.0001.

    Journal: Poultry Science

    Article Title: The adiponectin receptor agonist AdipoRon alleviates lipotoxic injury in LMH cells

    doi: 10.1016/j.psj.2026.106573

    Figure Lengend Snippet: Effects of inhibiting and activating AMPK signaling on the expression of key signaling molecules of adiponectin that regulate lipid metabolism in LMH cells. (A) Relative mRNA expression of AdipoR1, AdipoR2, and AMPK. (B) Protein expression of AdipoR1, AdipoR2, AMPK, and p-AMPK. Abbreviations: C, control group; H, mixed fatty acid (0.30 mM OA + 0.15 mM PA)-treated group; H+MA, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon-treated group; H+MA+C, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 10 μM Compound C-treated group; H+MA+A, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 0.5 mM AICAR-treated group; OA, oleic acid; PA, palmitic acid; AdipoR1, adiponectin receptor 1; AdipoR2, adiponectin receptor 2; AMPK, adenosine 5′-monophosphate-activated protein kinase. All data are expressed as the mean±SEM. * indicates P <0.05; ** indicates P <0.01; *** indicates P <0.001; ⁎⁎⁎⁎ indicates P <0.0001.

    Article Snippet: To determine whether AdipoRon alleviates mixed fatty acid-induced lipotoxic injury in LMH cells via AMPK signaling, the cells were grouped and treated as follows: cells in the control group (Group C) were cultured in normal serum-free medium; cells in the model group (Group H) were cultured in serum-free medium supplemented with mixed fatty acids (0.30 mM OA + 0.15 mM PA); cells in the fatty acid + medium AdipoRon group (Group H+MA) were cultured in serum-free medium supplemented with mixed fatty acids (0.30 mM OA + 0.15 mM PA) and 40 μM AdipoRon; cells in the AMPK antagonist Compound C group (Group H+MA+C) were cultured in serum-free medium supplemented with mixed fatty acids (0.30 mM OA + 0.15 mM PA), 40 μM AdipoRon, and 10 μM Compound C (Cat# HY-13418A, MedChemExpress); and cells in the AMPK agonist Acadesine (AICAR) group (Group H+MA+A) were cultured in serum-free medium supplemented with mixed fatty acids (0.30 mM OA + 0.15 mM PA), 40 μM AdipoRon, and 0.5 mM AICAR (Cat# HY-13417, MedChemExpress).

    Techniques: Expressing, Control

    Effects of inhibiting and activating AMPK signaling on lipid components in LMH cells. (A) Z score plot for Group C vs. Group H vs. Group H+MA vs. Group H+MA+A vs. Group H+MA+C. The Z score plot normalizes differential lipid molecules across different samples by calculating Z score values. The calculation formula is z=(x-μ)/σ, where x represents a specific score, μ denotes the mean, and σ indicates the standard deviation. The horizontal axis displays Z score values, the vertical axis shows differential lipids, and the differently colored points indicate samples from different groups. (B) Heatmap plot for Group C vs. Group H vs. Group H+MA vs. Group H+MA+A vs. Group H+MA+C. The horizontal axis represents different experimental groups, whereas the vertical axis denotes the differentially expressed lipid molecules within each group. The expression level of each lipid is indicated by a color gradient, with darker shades reflecting greater statistical significance. Color blocks at different positions represent the relative expression levels of corresponding lipid molecules at those positions: red indicates high expression of the substance in that group, while blue indicates low expression. (C) KEGG pathway annotation classification diagram for Group C vs. Group H vs. Group H+MA vs. Group H+MA+A vs. Group H+MA+C. The horizontal axis represents the enrichment ratio for each pathway, while the vertical axis displays the names of the metabolic pathways. Colors indicate the magnitude of p values, with redder hues corresponding to smaller p values, signifying more significant enrichment. Abbreviations: C, control group; H, mixed fatty acid (0.30 mM OA + 0.15 mM PA)-treated group; H+MA, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon-treated group; H+MA+A, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 0.5 mM AICAR-treated group; H+MA+C, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 10 μM Compound C-treated group; OA, oleic acid; PA, palmitic acid; TAG, triacylglycerol; PG, phosphatidylglycerol; PetOH, phosphatidylethanol; PE, phosphatidylethanolamine; PC, phosphatidylcholine; HexCer-NS, hexosylceramide nonhydroxyfatty acid-sphingosine; HexCer-AP, hexosylceramide alpha-hydroxy fatty acid-phytosphingosine; GlcADG, glucuronosyldiacylglycerol; Cer-AP, ceramide alpha-hydroxy fatty acid-phytosphingosine; ACar, acylcarnitine.

    Journal: Poultry Science

    Article Title: The adiponectin receptor agonist AdipoRon alleviates lipotoxic injury in LMH cells

    doi: 10.1016/j.psj.2026.106573

    Figure Lengend Snippet: Effects of inhibiting and activating AMPK signaling on lipid components in LMH cells. (A) Z score plot for Group C vs. Group H vs. Group H+MA vs. Group H+MA+A vs. Group H+MA+C. The Z score plot normalizes differential lipid molecules across different samples by calculating Z score values. The calculation formula is z=(x-μ)/σ, where x represents a specific score, μ denotes the mean, and σ indicates the standard deviation. The horizontal axis displays Z score values, the vertical axis shows differential lipids, and the differently colored points indicate samples from different groups. (B) Heatmap plot for Group C vs. Group H vs. Group H+MA vs. Group H+MA+A vs. Group H+MA+C. The horizontal axis represents different experimental groups, whereas the vertical axis denotes the differentially expressed lipid molecules within each group. The expression level of each lipid is indicated by a color gradient, with darker shades reflecting greater statistical significance. Color blocks at different positions represent the relative expression levels of corresponding lipid molecules at those positions: red indicates high expression of the substance in that group, while blue indicates low expression. (C) KEGG pathway annotation classification diagram for Group C vs. Group H vs. Group H+MA vs. Group H+MA+A vs. Group H+MA+C. The horizontal axis represents the enrichment ratio for each pathway, while the vertical axis displays the names of the metabolic pathways. Colors indicate the magnitude of p values, with redder hues corresponding to smaller p values, signifying more significant enrichment. Abbreviations: C, control group; H, mixed fatty acid (0.30 mM OA + 0.15 mM PA)-treated group; H+MA, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon-treated group; H+MA+A, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 0.5 mM AICAR-treated group; H+MA+C, mixed fatty acid (0.30 mM OA + 0.15 mM PA) + 40 μM AdipoRon + 10 μM Compound C-treated group; OA, oleic acid; PA, palmitic acid; TAG, triacylglycerol; PG, phosphatidylglycerol; PetOH, phosphatidylethanol; PE, phosphatidylethanolamine; PC, phosphatidylcholine; HexCer-NS, hexosylceramide nonhydroxyfatty acid-sphingosine; HexCer-AP, hexosylceramide alpha-hydroxy fatty acid-phytosphingosine; GlcADG, glucuronosyldiacylglycerol; Cer-AP, ceramide alpha-hydroxy fatty acid-phytosphingosine; ACar, acylcarnitine.

    Article Snippet: To determine whether AdipoRon alleviates mixed fatty acid-induced lipotoxic injury in LMH cells via AMPK signaling, the cells were grouped and treated as follows: cells in the control group (Group C) were cultured in normal serum-free medium; cells in the model group (Group H) were cultured in serum-free medium supplemented with mixed fatty acids (0.30 mM OA + 0.15 mM PA); cells in the fatty acid + medium AdipoRon group (Group H+MA) were cultured in serum-free medium supplemented with mixed fatty acids (0.30 mM OA + 0.15 mM PA) and 40 μM AdipoRon; cells in the AMPK antagonist Compound C group (Group H+MA+C) were cultured in serum-free medium supplemented with mixed fatty acids (0.30 mM OA + 0.15 mM PA), 40 μM AdipoRon, and 10 μM Compound C (Cat# HY-13418A, MedChemExpress); and cells in the AMPK agonist Acadesine (AICAR) group (Group H+MA+A) were cultured in serum-free medium supplemented with mixed fatty acids (0.30 mM OA + 0.15 mM PA), 40 μM AdipoRon, and 0.5 mM AICAR (Cat# HY-13417, MedChemExpress).

    Techniques: Standard Deviation, Expressing, Control